IgA Nephropathy in the Elderly

Introduction: Knowledge about IgA nephropathy (IgAN) presentation and prognosis for elderly patients is limited. We assessed clinical and histologic findings among patients aged ≥ 60 years at diagnosis and examined factors associated with the risk of kidney failure and death. Methods: We identified...

Full description

Saved in:
Bibliographic Details
Main Authors: Dana V. Rizk, Emily Dryer, Ashutosh Tamhane, Jan Novak, Bruce A. Julian, Robert J. Wyatt
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Kidney International Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925003146
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849247496761507840
author Dana V. Rizk
Emily Dryer
Ashutosh Tamhane
Jan Novak
Bruce A. Julian
Robert J. Wyatt
author_facet Dana V. Rizk
Emily Dryer
Ashutosh Tamhane
Jan Novak
Bruce A. Julian
Robert J. Wyatt
author_sort Dana V. Rizk
collection DOAJ
description Introduction: Knowledge about IgA nephropathy (IgAN) presentation and prognosis for elderly patients is limited. We assessed clinical and histologic findings among patients aged ≥ 60 years at diagnosis and examined factors associated with the risk of kidney failure and death. Methods: We identified those patients at our center between 1996 and 2020. Age, sex, race, chronic kidney disease (CKD) stage, and histologic MEST-C classification at biopsy were collected. Outcomes of kidney failure and death were ascertained by using United States Renal Data System (USRDS) and National Death Index (NDI), respectively. Associations of baseline predictors with kidney failure were examined by using cause-specific Cox hazards regression with all-cause mortality as competing risk. For all-cause mortality, standard Cox proportional hazards regression analysis was used. Cumulative survival probabilities were examined using Kaplan-Meier survival curves. Results: Among 127 patients, median estimated glomerular filtration rate (eGFR) was 25 ml/min per 1.73 m2, 81% had proteinuria ≥ 1000 mg/g creatinine, 35% and 17% had CKD stages 4 and 5, respectively. Forty-five patients progressed to kidney failure and 86 died. Overall, Kaplan-Meier estimate of median time to kidney failure was 11.3 years and to death was 7.5 years. Males were more likely to progress to kidney failure than females. Kidney failure strongly associated with CKD stages 3, 4, and 5 versus stages 1 or 2; findings remained unchanged after adjusting for histology. Mortality was associated with increasing age and advanced CKD. Conclusion: IgAN diagnosed at elderly age is associated with severe clinical phenotype and portends a poor prognosis because of high risk of kidney failure and death.
format Article
id doaj-art-8fbffb4d7fc64bd9aabe256f365418e3
institution Kabale University
issn 2468-0249
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-8fbffb4d7fc64bd9aabe256f365418e32025-08-20T03:58:11ZengElsevierKidney International Reports2468-02492025-08-011082651265810.1016/j.ekir.2025.05.012IgA Nephropathy in the ElderlyDana V. Rizk0Emily Dryer1Ashutosh Tamhane2Jan Novak3Bruce A. Julian4Robert J. Wyatt5Division of Nephrology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA; Correspondence: Dana V. Rizk, Division of Nephrology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, ZRB 614, 1720 2nd Avenue South Birmingham, Alabama 35294, USA.Division of Nephrology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA; Munson Healthcare Kidney and Hypertension Specialists, Traverse City, Michigan, USADivision of Nephrology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USADepartment of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USADivision of Nephrology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USADepartment of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA; Children’s Foundation Research Institute, Memphis, Tennessee, USAIntroduction: Knowledge about IgA nephropathy (IgAN) presentation and prognosis for elderly patients is limited. We assessed clinical and histologic findings among patients aged ≥ 60 years at diagnosis and examined factors associated with the risk of kidney failure and death. Methods: We identified those patients at our center between 1996 and 2020. Age, sex, race, chronic kidney disease (CKD) stage, and histologic MEST-C classification at biopsy were collected. Outcomes of kidney failure and death were ascertained by using United States Renal Data System (USRDS) and National Death Index (NDI), respectively. Associations of baseline predictors with kidney failure were examined by using cause-specific Cox hazards regression with all-cause mortality as competing risk. For all-cause mortality, standard Cox proportional hazards regression analysis was used. Cumulative survival probabilities were examined using Kaplan-Meier survival curves. Results: Among 127 patients, median estimated glomerular filtration rate (eGFR) was 25 ml/min per 1.73 m2, 81% had proteinuria ≥ 1000 mg/g creatinine, 35% and 17% had CKD stages 4 and 5, respectively. Forty-five patients progressed to kidney failure and 86 died. Overall, Kaplan-Meier estimate of median time to kidney failure was 11.3 years and to death was 7.5 years. Males were more likely to progress to kidney failure than females. Kidney failure strongly associated with CKD stages 3, 4, and 5 versus stages 1 or 2; findings remained unchanged after adjusting for histology. Mortality was associated with increasing age and advanced CKD. Conclusion: IgAN diagnosed at elderly age is associated with severe clinical phenotype and portends a poor prognosis because of high risk of kidney failure and death.http://www.sciencedirect.com/science/article/pii/S2468024925003146elderlyIgA nephropathyIgANkidney failuremortality
spellingShingle Dana V. Rizk
Emily Dryer
Ashutosh Tamhane
Jan Novak
Bruce A. Julian
Robert J. Wyatt
IgA Nephropathy in the Elderly
Kidney International Reports
elderly
IgA nephropathy
IgAN
kidney failure
mortality
title IgA Nephropathy in the Elderly
title_full IgA Nephropathy in the Elderly
title_fullStr IgA Nephropathy in the Elderly
title_full_unstemmed IgA Nephropathy in the Elderly
title_short IgA Nephropathy in the Elderly
title_sort iga nephropathy in the elderly
topic elderly
IgA nephropathy
IgAN
kidney failure
mortality
url http://www.sciencedirect.com/science/article/pii/S2468024925003146
work_keys_str_mv AT danavrizk iganephropathyintheelderly
AT emilydryer iganephropathyintheelderly
AT ashutoshtamhane iganephropathyintheelderly
AT jannovak iganephropathyintheelderly
AT bruceajulian iganephropathyintheelderly
AT robertjwyatt iganephropathyintheelderly